# Neurocrine Biosciences Inc: Form 8-K/A, filed Jul 31, 2026

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K/A
- Filed: 2026-07-31
- Accepted by EDGAR: Jul 31, 2026, 16:05 ET
- Period: 2026-05-14
- Accession: 0001193125-26-328470
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000119312526328470/d73154d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000119312526328470/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000119312526328470/d73154d8ka.htm

Filed Jul 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-328470. Last ingested by Listed: Nov 11, 2026, 02:29 ET. No prices; not investment advice.
